Saturday 17 October 2026
Export OSUR’s income statement to Excel — free account
OraSure Technologies, Inc.
OSUR Healthcare Medical Instruments & Supplies
OraSure Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $115.0 million, down 38.1% from fiscal 2024. In the quarter to June 2026, revenue fell 1.93%, EPS grew 134.6%, free cash flow fell 1.40% and total debt fell 8.27%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
3.61
0.20
−5.25%
Follow OSUR
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
25.11 | 36.40 | 34.35 | 29.74 | 0.00 | 0.00 | 0.00 | 11.50 | 0.00 | 0.00 |
Piotroski F-Score |
9 | 5 | 6 | 2 | 3 | 1 | 4 | 8 | 5 | 3 |
Altman Z-Score |
13.99 | 18.75 | 14.46 | 8.00 | 8.35 | 5.34 | 3.60 | 8.60 | 2.97 | 1.47 |
P/S ratio |
3.81 | 6.82 | 3.93 | 3.20 | 4.16 | 2.68 | 0.90 | 1.50 | 1.45 | 1.55 |
P/FCF ratio |
24.15 | 47.82 | 21.80 | 1,010.71 | 0.00 | 0.00 | 0.00 | 4.63 | 11.40 | 0.00 |
Altman Z″-Score (non-manufacturers) |
11.52 | 10.91 | 12.80 | 10.84 | 10.21 | 7.26 | 7.24 | 13.27 | 9.22 | 6.76 |
Beneish M-Score |
(2.48) | (1.47) | (2.77) | (2.26) | (2.65) | (2.28) | (1.59) | (3.69) | (2.76) | (2.73) |
P/Operating CF |
(839.96) | (516.59) | 49.97 | (478.97) | 197.97 | (48.93) | (19.28) | 14.68 | 2,465.20 | (19.77) |
P/B ratio |
2.63 | 4.41 | 2.52 | 1.61 | 1.79 | 1.64 | 0.95 | 1.41 | 0.65 | 0.52 |
Price to Tangible BV |
3.12 | 4.96 | 2.75 | 1.93 | 2.10 | 1.92 | 1.09 | 1.54 | 0.76 | 0.64 |
EV/Sales |
2.87 | 5.89 | 3.07 | 2.20 | 2.95 | 2.03 | 0.61 | 0.78 | 0.01 | (0.19) |
EV/EBITDA |
14.18 | 21.23 | 15.98 | 13.11 | 120.28 | 317.55 | 0.00 | 5.91 | 0.00 | 0.35 |
EV/Operating CF |
14.96 | 34.92 | 14.25 | 34.71 | 87.20 | (13.41) | (5.02) | 2.24 | 0.04 | 0.44 |
EV/FCF |
18.17 | 41.28 | 17.02 | 694.46 | (24.27) | (5.68) | (2.13) | 2.42 | 0.04 | 0.40 |
Quick Ratio |
8.12 | 6.16 | 6.84 | 5.91 | 5.34 | 2.91 | 2.63 | 8.36 | 8.71 | 5.57 |
Current Ratio |
9.02 | 6.88 | 7.84 | 6.86 | 6.21 | 4.40 | 4.71 | 9.77 | 9.95 | 6.58 |
Net Debt/EBITDA |
(4.66) | (3.37) | (4.49) | (5.97) | (49.53) | (101.13) | 16.11 | (5.41) | 15.40 | 3.22 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.39% | 0.20% | 0.42% | 0.11% | 0.05% | 0.02% | 0.02% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.65 | 0.66 | 0.59 | 0.47 | 0.43 | 0.51 | 0.86 | 0.87 | 0.39 | 0.26 |
Operating CF/Net income |
1.25 | 0.91 | 1.92 | 0.59 | (0.39) | 1.54 | 2.76 | 2.64 | (1.40) | 0.71 |
Capex/Depreciation |
(0.77) | (0.71) | (0.98) | (1.27) | (3.08) | (4.13) | (4.17) | (0.49) | (0.35) | (0.41) |
| 11.42% | 13.94% | 7.53% | 5.64% | (4.23%) | (5.90%) | (4.60%) | 13.50% | (4.64%) | (18.30%) | |
| 9.93% | 12.28% | 6.67% | 5.01% | (3.71%) | (5.02%) | (3.79%) | 11.58% | (4.05%) | (15.57%) | |
ROIC |
19.52% | 24.61% | 14.01% | 7.64% | (1.70%) | (2.77%) | (5.45%) | 14.54% | (12.37%) | (31.75%) |
Return on Tangible Assets |
12.39% | 14.66% | 9.46% | 7.50% | (5.07%) | (7.55%) | (5.43%) | 13.68% | (5.65%) | (26.30%) |
Average Days of Receivables |
56.45 | 92.90 | 69.97 | 87.23 | 82.55 | 70.79 | 66.69 | 36.16 | 46.78 | 70.46 |
Research and Development Expense of Revenue |
7.61% | 8.00% | 8.94% | 12.70% | 18.07% | 14.62% | 9.35% | 8.32% | 14.02% | 36.97% |
Selling, General and Administrative Expense of Revenue |
45.25% | 34.63% | 37.93% | 43.44% | 44.91% | 40.69% | 30.31% | 23.31% | 41.54% | 64.16% |
Intangible Assets out of Total Assets |
0.14 | 0.10 | 0.08 | 0.15 | 0.13 | 0.12 | 0.11 | 0.08 | 0.12 | 0.15 |
Share Based Compensation of Revenue |
4.73% | 4.17% | 8.38% | 2.62% | 4.16% | 3.34% | 3.00% | 2.65% | 6.41% | 8.82% |
Graham Net Nets |
0.27 | 0.16 | 0.26 | 0.37 | 0.33 | 0.35 | 0.71 | 0.55 | 0.98 | 1.12 |
Graham Number |
5.13 | 7.22 | 5.96 | 5.50 | 0.00 | 0.00 | 0.00 | 9.75 | 0.00 | 0.00 |
Earnings Yield |
3.98% | 2.75% | 2.91% | 3.36% | (2.22%) | (3.68%) | (5.43%) | 8.70% | (7.20%) | (38.43%) |
Free Cash Flow Yield |
4.14% | 2.09% | 4.59% | 0.10% | (2.92%) | (13.35%) | (31.96%) | 21.62% | 8.77% | (29.93%) |
Revenue per Share |
2.31 | 2.83 | 2.97 | 2.51 | 2.54 | 3.25 | 5.34 | 5.53 | 2.50 | 1.57 |
Operating CF per Share |
0.44 | 0.48 | 0.64 | 0.16 | 0.09 | (0.49) | (0.65) | 1.93 | 0.37 | (0.67) |
Capex per Share |
(0.08) | (0.07) | (0.10) | (0.15) | (0.43) | (0.67) | (0.88) | (0.14) | (0.05) | (0.06) |
Free Cash Flow per Share |
0.36 | 0.40 | 0.54 | 0.01 | (0.34) | (1.16) | (1.53) | 1.79 | 0.32 | (0.72) |
Cash per Share |
2.17 | 2.64 | 2.56 | 2.53 | 3.10 | 2.13 | 1.53 | 3.96 | 3.60 | 2.71 |
Shareholders Equity per Share |
3.34 | 4.37 | 4.64 | 4.98 | 5.90 | 5.29 | 5.03 | 5.87 | 5.51 | 4.64 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
3.34 | 4.37 | 4.64 | 4.98 | 5.90 | 5.29 | 5.03 | 5.87 | 5.51 | 4.64 |
Free Cash Flow |
20.25 | 23.82 | 32.75 | 0.49 | (23.12) | (83.50) | (110.99) | 131.28 | 23.58 | (53.22) |
Working Capital |
139.11 | 189.67 | 191.33 | 191.84 | 242.40 | 231.24 | 256.13 | 346.92 | 299.74 | 222.11 |
Capital Expenditures |
(4.35) | (4.34) | (6.34) | (9.31) | (28.92) | (48.12) | (63.79) | (10.30) | (3.80) | (4.20) |
Net Current Asset Value |
134.36 | 183.79 | 187.12 | 182.40 | 232.99 | 218.85 | 245.44 | 334.29 | 263.90 | 199.57 |
EV/EBIT |
18.15 | 24.43 | 19.60 | 18.28 | 0.00 | 0.00 | 0.00 | 9.70 | 0.00 | 0.30 |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.06 | 0.17 | 0.21 | 0.16 | 0.03 | 0.02 | 0.04 |
Price to Operating Income |
24.12 | 28.31 | 25.11 | 26.61 | 0.00 | 0.00 | 0.00 | 18.58 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.28 | 0.28 | 0.27 | 0.24 | 0.18 | 0.16 | 0.26 | 0.46 | 0.24 | 0.26 |
Cash ROIC |
6.60% | 5.75% | 7.44% | 0.11% | (3.80%) | (15.59%) | (23.33%) | 18.20% | 3.48% | (9.85%) |
Accounts Receivable Turnover |
6.56 | 5.36 | 4.70 | 4.31 | 4.53 | 5.55 | 6.67 | 7.31 | 5.81 | 5.00 |
Accounts Payable Turnover |
8.27 | 9.17 | 6.54 | 5.95 | 5.18 | 5.11 | 7.24 | 9.14 | 9.98 | 9.10 |
Inventory Turnover |
3.21 | 4.37 | 3.23 | 2.61 | 2.54 | 2.73 | 3.21 | 3.26 | 2.60 | 2.05 |
Average Days of Payables |
42.10 | 54.81 | 56.78 | 58.18 | 90.96 | 88.12 | 58.05 | 20.53 | 28.03 | 35.62 |
Days of Inventory on Hand |
107.21 | 103.66 | 122.62 | 140.81 | 166.49 | 167.09 | 146.13 | 74.33 | 117.27 | 169.66 |
Average Receivables |
19.55 | 31.17 | 38.68 | 35.90 | 37.89 | 42.08 | 58.06 | 55.48 | 31.99 | 23.01 |
Average Payables |
4.86 | 7.43 | 10.41 | 10.08 | 13.49 | 22.72 | 33.02 | 25.59 | 10.66 | 7.35 |
Average Inventory |
12.52 | 15.57 | 21.12 | 23.02 | 27.51 | 42.50 | 74.42 | 71.66 | 40.91 | 32.63 |
Average Assets |
198.63 | 252.07 | 305.89 | 332.43 | 401.88 | 457.73 | 452.59 | 463.51 | 481.25 | 441.41 |
Average Common Equity |
172.64 | 221.97 | 270.73 | 295.26 | 352.86 | 389.55 | 372.48 | 397.55 | 420.50 | 375.58 |
Columns are period end dates